Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system
Authors:
- 1 July 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 119, 171-178
Abstract
No abstract availableKeywords
Funding Information
- King Saud University (RGP-212)
This publication has 43 references indexed in Scilit:
- Controlled-release and preserved bioactivity of proteins from (self-assembled) core-shell double-walled microspheresInternational Journal of Nanomedicine, 2012
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010
- Polymer Therapeutics: Concepts and ApplicationsAngewandte Chemie International Edition, 2006
- Need for Early Antifungal Treatment Confirmed in Experimental Disseminated Candida albicans InfectionAntimicrobial Agents and Chemotherapy, 2004
- A Randomized, Double‐Blind, Placebo‐Controlled Trial of Acetazolamide for the Treatment of Elevated Intracranial Pressure in Cryptococcal MeningitisClinical Infectious Diseases, 2002
- Use of Ventriculoperitoneal Shunts to Treat Uncontrollable Intracranial Hypertension in Patients Who Have Cryptococcal Meningitis without HydrocephalusClinical Infectious Diseases, 2002
- Practice Guidelines for the Management of Cryptococcal DiseaseClinical Infectious Diseases, 2000
- FluconazoleDrugs, 1995
- Clinical Pharmacokinetics of FluconazoleClinical Pharmacokinetics, 1993
- Fluconazole Therapy for Experimental Cryptococcosis and Candidiasis in the RabbitClinical Infectious Diseases, 1990